Swiss CDMO Lonza plans to invest an undisclosed sum to establish drug product manufacturing capabilities at its site in Guangzhou, China. The investment in the central...
Fu Xiangsheng, Vice Chairman of the China Petroleum and Chemical Industry Federation, characterized China`s chemical industry as having a a surplus of basic chemicals and...
South Korean chemical giant LG Chem has announced plans to invest 2.6 trillion won – or $2.2 billion – in building 10 new plants for environmentally friendly materials by...
The increasing complexity of drug products brings pharmaceutical companies significant manufacturing challenges arising from the pandemic. This includes disrupting supply...
Curia, the US CDMO formerly known as AMRI, has announced it will invest $35 million to expand commercial manufacturing capacity at its Rensselaer, New York, production...
Alex Gorsky, chairman and CEO of Johnson & Johnson since 2012, has announced he will step down from the healthcare giant’s top slot at the beginning of 2022 and hand over...
Dow is investing an undisclosed sum in its methyl acrylate production to meet growing demand both in North America and worldwide. The project at its St Charles operations...
US drugmaker Eli Lilly has announced changes to its executive leadership team as it creates two new business units in order to strengthen its focus on introducing...
After more than a decade, the US Environmental Protection Agency (EPA) is finally moving to block the use of the controversial insecticide active ingredient chorpyrifos...
US biotech Novavax, in the final stage of developing its protein-based Covid-19 vaccine, NVX-CoV2373, is adding muscle in human resources before applying to the US Food...
